Epigenetic remodelling of DNA methylation shapes synovial macrophage–fibroblast-like synoviocytes crosstalk in rheumatoid arthritis
Autoimmunity Reviews · 2026-11 · 104239
DOI: 10.1016/j.autrev.2026.104239 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Autoimmunity Reviews, 2026-11. Verfasst von Yan Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Beijing University of Chinese Medicine, School of Clinical Medicine, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Clinical Me…. Die Arbeit nennt 148 Literaturangaben.
Abstract (Originalsprache)
Macrophages and fibroblast-like synoviocytes (FLSs) are key cellular components of the rheumatoid arthritis (RA) synovial microenvironment and together constitute a pathogenic niche that drives immune infiltration, synovial hyperplasia and joint destruction. Under physiological conditions, macrophages contribute to the maintenance of synovial immune balance and stromal homeostasis. Dysregulated macrophage-FLSs crosstalk amplifies inflammatory signalling, promotes invasive phenotypes and sustains chronic synovitis through self-reinforcing feedback mechanisms in RA. These processes are closely linked to epigenetic remodelling, which may precede clinical manifestations of disease. In RA, aberrant DNA methylation patterns reprogramme disease-relevant gene expression networks, involving DNMT-mediated methylation, TET-mediated active demethylation, UHRF1 maintenance, thereby influencing disease susceptibility, inflammation persistence, tissue invasiveness and therapeutic response. Moreover, DNA methylation acts in concert with other regulatory layers, including RNA methylation modification and histone modification, to shape the temporal and spatial heterogeneity of macrophage-FLSs crosstalk. Therefore, it is necessary to seek new therapeutic approaches. Targeting DNA methylation to regulate the inflammatory response and invasive function in cancer has shown clinical efficacy and provides a possibility for specifically targeting synovial macrophage-FLSs crosstalk. Therefore, targeted treatment of DNA methylation-driven crosstalk between macrophages and FLSs may be a promising alternative method for the prevention and treatment of RA.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing University of Chinese Medicine, School of Clinical Medicine, China-Japan Friendship Hospital, Beijing 100029, China; Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
- Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing 100029, China; Chinese Academy of Medical Sciences & Peking Union Medical College, China-Japan Friendship Clinical Medical College, Beijing 100029…
- Department of Rheumatology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
- Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: xc2002812@126.com.
- Institute of Clinical Medicine, China-Japan Friendship Hospital, Beijing 100029, China. Electronic address: ttdeng1983@163.com.
Zitieren
APA
Wang, Y., Shi, T., Zhang, H., Zhang, J., Wen, C., Zhang, K., Su, S., Lv, S., Xiao, C., & Deng, T. (2026). Epigenetic remodelling of DNA methylation shapes synovial macrophage–fibroblast-like synoviocytes crosstalk in rheumatoid arthritis. Autoimmunity Reviews, 104239. https://doi.org/10.1016/j.autrev.2026.104239
Vancouver
Wang Y, Shi T, Zhang H, Zhang J, Wen C, Zhang K, et al. Epigenetic remodelling of DNA methylation shapes synovial macrophage–fibroblast-like synoviocytes crosstalk in rheumatoid arthritis. Autoimmunity Reviews. 2026:104239. doi:10.1016/j.autrev.2026.104239
BibTeX
@article{Wang2026,
author = {Wang, Yan and Shi, Tong and Zhang, Hanyu and Zhang, Jiaxi and Wen, Chaoying and Zhang, Kai and Su, Sicheng and Lv, Shuang and Xiao, Cheng and Deng, Tingting},
title = {Epigenetic remodelling of DNA methylation shapes synovial macrophage–fibroblast-like synoviocytes crosstalk in rheumatoid arthritis},
journal = {Autoimmunity Reviews},
year = {2026},
pages = {104239},
doi = {10.1016/j.autrev.2026.104239}
}
EUVIMED